Dexamethasone

Dexamethasone is a potent synthetic glucocorticoid that suppresses inflammation and modulates the immune response. It works by binding to intracellular glucocorticoid receptors, altering gene transcription, and reducing the production of inflammatory mediators such as prostaglandins and cytokines.

Why it matters in dentistry

• Post‑operative swelling and pain – A single low‑dose tablet (often 4 mg) given pre‑ or post‑operatively can markedly reduce facial edema after extractions, periodontal surgery, or implant placement.
• Management of acute oral lesions – Helps control severe inflammatory lesions (e.g., aphthous ulcers, pemphigus vulgaris flares).
• Adjunct to chemotherapy‑induced nausea – Useful for patients undergoing cancer‑related oral surgery who are receiving dexamethasone for anti‑emesis.

Typical dental dosing

Indication	Common oral tablet dose*	Frequency	Duration
Minor oral surgery (e.g., single-tooth extraction)	4 mg	Single dose pre-op or within 1 h post-op	1-2 days
Major oral surgery (e.g., third-molar removal, bone graft)	4-8 mg	Split dose (e.g., 4 mg BID)	3-5 days
Severe oral inflammatory conditions	4-6 mg	BID	5-7 days, taper if >7 days

\*Tablets are available in 0.5 mg, 1 mg, 2 mg, and 4 mg strengths; dosing is adjusted for patient weight, comorbidities, and concomitant steroids.

Safety profile – the most critical points

• No FDA black‑box warning, but systemic corticosteroids carry serious risks when used repeatedly or at high doses.
• Contraindications – active systemic fungal infection, uncontrolled diabetes, uncontrolled hypertension, peptic ulcer disease, severe osteoporosis, recent live‑virus vaccination, and known hypersensitivity to dexamethasone.
• Key adverse effects – fluid retention, elevated blood pressure, hyperglycemia, mood swings, insomnia, gastric irritation, and potential adrenal suppression with prolonged use.
• Drug interactions – potentiates anticoagulants (warfarin), may increase NSAID‑related GI toxicity, interacts with CYP3A4 inhibitors (e.g., ketoconazole) and inducers (e.g., rifampin), and can blunt the efficacy of live vaccines.

Patient counseling tips

• Take the tablet with food to minimize stomach upset.
• Report any sudden increase in swelling, fever, or signs of infection—corticostids can mask symptoms.
• Diabetic patients should monitor blood glucose closely for a few days after the dose.
• Avoid abrupt discontinuation after >5 days of therapy; taper if longer courses are needed.

When to consider alternatives

• For mild postoperative discomfort, NSAIDs alone may suffice.
• In patients with uncontrolled diabetes or severe hypertension, a short course of a non‑steroidal anti‑inflammatory (e.g., ibuprofen) combined with cold therapy may be safer.

Quick Reference

• Indication: Post‑op swelling, severe oral inflammation, adjunct anti‑emetic.
• Typical dose: 4 mg single dose or 4–8 mg divided BID for 3–5 days.
• Major contraindications: Active systemic fungal infection, uncontrolled diabetes/hypertension, recent live vaccine.
• Key monitoring: Blood pressure, glucose, GI symptoms, mood changes.
• Interaction alert: Watch for warfarin, NSAIDs, CYP3A4 modulators.

Clinical Pearls

💡 Give the tablet 30‑60 minutes before surgery for maximal anti‑edema effect.

💡 In diabetic patients, a 4 mg dose typically raises glucose <30 mg/dL; schedule a follow‑up glucose check.

💡 Combine with a short course of a proton‑pump inhibitor if the patient has a history of ulcers.

💡 For patients on anticoagulants, monitor INR closely if dexamethasone is used for >3 days.

💡 Taper only when the course exceeds 5 days to avoid adrenal insufficiency.

FAQ